SalMar ASA (OSL:SALM)

Market Cap	56.18B
Revenue (ttm)	24.73B
Net Income (ttm)	1.79B
Shares Out	133.64M
EPS (ttm)	13.58
PE Ratio	30.97
Forward PE	12.85
Dividend	22.00 (5.24%)
Ex-Dividend Date	Jun 19, 2025

Volume	195,305
Average Volume	277,357
Open	418.80
Previous Close	420.00
Day's Range	414.40 - 423.40
52-Week Range	407.20 - 646.50
Beta	0.61
RSI	43.92
Earnings Date	Aug 21, 2025

About Revance Therapeutics

SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, North America, Europe, and internationally. The company operates through Fish Farming Central Norway, Fish Farming Northern Norway, Icelandic Salmon, Sales & Industry, and SalMar Aker Ocean segments. It engages in the broodstock, marine-phase farming, harvesting, processing, and smolt production activities. In addition, the company offers fish fillets and related products. SalMar ASA was incorporated in 1991 and is headquartered in Kverva, Norway.

• Industry: Farm Products
• Sector: Consumer Staples
• Founded: 1991
• Employees: 3,345
• Stock Exchange: Oslo Børs
• Ticker Symbol: SALM

Financial Performance

In 2024, SalMar ASA's revenue was 26.08 billion, a decrease of -6.50% compared to the previous year's 27.89 billion. Earnings were 2.97 billion, a decrease of -7.31%.